1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.

Study on Beta Cell Preservation for Newly Diagnosed Ages 6-21

Discussion in 'General Discussion' started by Jeff, Apr 11, 2017.

  1. Jeff

    Jeff Founder, CWD

    Jun 1, 1995
    A new study is underway to investigate a drug to preserve beta cell function in newly diagnosed people ages 6-21.

    The study is called T1GER.

    From their web site:

    The purpose of the T1GER clinical research study is to determine the safety and efficacy of an investigational medication in children and young adults with newly diagnosed type 1 diabetes. The investigational medication is being tested to find out if it can maintain beta cell (insulin-producing) function in the pancreas of those newly diagnosed with type 1 diabetes.

    For study center locations and more information see:
  2. joshualevy

    joshualevy Approved members

    Dec 30, 2008

Share This Page